InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (10 ops.)
Explore the complete record of transactions filed by Jakobovits Aya, Director. Director active across 1 companies, notably Adicet Bio, Inc.. In total, 10 reports have been logged. Total volume traded: €389k. The latest transaction was filed on 9 March 2022 (Cession). Regulator: SEC (Form 4). All data is free.
Declarations10 total
€25,6922,000 shares@ €12.84610.032% mcap6.6% of flow
Common Stock
SEC:0001209191-22-018158:0·
€26,1202,000 shares@ €13.05990.032% mcap6.7% of flow
Common Stock
SEC:0001209191-22-010952:0·
€26,1202,000 shares@ €13.05990.032% mcap19.4% of flow
Common Stock
SEC:0001209191-22-010952·
€95,0686,000 shares@ €15.84460.12% mcap24.4% of flow
Common Stock
SEC:0001209191-22-009417:0·
€17,7001,924 shares@ €9.19960.022% mcap13.2% of flow
Common Stock
SEC:0001209191-21-041630·
€17,7001,924 shares@ €9.19960.022% mcap4.5% of flow
Common Stock
SEC:0001209191-21-041630:0·
€35,7303,108 shares@ €11.4960.044% mcap26.6% of flow
Common Stock
SEC:0001209191-21-034631·
€35,7303,108 shares@ €11.4960.044% mcap9.2% of flow
Common Stock
SEC:0001209191-21-034631:0·
€54,7485,000 shares@ €10.94970.068% mcap40.8% of flow
Common Stock
SEC:0001209191-21-032740·
€54,7485,000 shares@ €10.94970.068% mcap14.1% of flow
Common Stock
SEC:0001209191-21-032740:0·
10 of 10 declarations
About Jakobovits Aya
Aya Jakobovits is a Board Member at Adicet Bio, Inc. She plays a key role in the company's governance, bringing her expertise in biotechnology and drug development. Jakobovits is involved in making strategic decisions that influence the direction of Adicet Bio. Her experience in the sector is a valuable asset to the board.
